- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1038/s41598-020-72801-1
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2020
- Urheber
-
Ernst, Lisa
Zieglowski, Leonie
Schulz, Mareike
Moss, Michaela
Meyer, Marco
Weiskirchen, Ralf
Palme, Rupert
Hamann, Melanie
Talbot, Steven R.
Tolba, René H.
- DOI
-
10.18154/RWTH-CONV-243456
- URN
-
urn:nbn:de:101:1-2023112400372127031276
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-03-25T13:51:20+0100
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ernst, Lisa
- Zieglowski, Leonie
- Schulz, Mareike
- Moss, Michaela
- Meyer, Marco
- Weiskirchen, Ralf
- Palme, Rupert
- Hamann, Melanie
- Talbot, Steven R.
- Tolba, René H.
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2020
Ähnliche Objekte (12)
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Cell therapy in liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Magnetic-assisted treatment of liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Cell therapy in liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Magnetic-assisted treatment of liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Cell therapy in liver fibrosis
CCNs and other extracellular matrix proteins: an introduction to the special issue
Established liver cell lines: are you sure to have the right ones?
Established Hepatic Stellate Cell Lines in Hepatology Research
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"